Technical Analysis for RHT - Resonance Health Limited  

Grade Last Price % Change Price Change
F 0.054 42.11% 0.016
RHT closed unchanged on Thursday, November 14, 2024, on 1.55 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
Boomer Sell Setup Bearish Swing Setup 42.11%
Calm After Storm Range Contraction 42.11%
Narrow Range Bar Range Contraction 42.11%
Wide Bands Range Expansion 42.11%
Oversold Stochastic Weakness 42.11%
Calm After Storm Range Contraction 42.11%
Narrow Range Bar Range Contraction 42.11%
Wide Bands Range Expansion 42.11%
Oversold Stochastic Weakness 42.11%
New 52 Week Closing Low Bearish 42.11%

   Recent Intraday Alerts

Alert Time
50 DMA Resistance about 2 hours ago
Possible Pocket Pivot about 3 hours ago
Up 10% about 3 hours ago
Gapped Up (Full) about 3 hours ago
Rose Above Previous Day's High about 3 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Resonance Health Limited   Description

Resonance Health Limited is principally engaged in the development and commercialization of technologies and services for the quantitative analysis of radiological images. The Company's segments include Services, Research and Development, and Corporate. The Company's core product is FerriScan, which is a non-invasive liver diagnostic technology used for the measurement of iron in the liver. FerriScan is used for liver iron concentration (LIC) measurement from magnetic resonance imaging (MRI) scans of a patient's liver. The FerriScan analysis procedure produces a mean LIC measurement and a color coded map reflecting the iron distribution across the liver. The Company's product HepaFat-Scan, is a non-invasive method for measuring volumetric liver fat fraction (VLFF) from MRI scans. HepaFat-Scan is provided as an image analysis service. HepaFat-Scan is available for routine clinical use and for use in pharmaceutical company clinical trials.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Health Iron Medicine Pharmaceutical Radio Imaging Medical Imaging Clinical Trial Measurement Medical Equipment Radiology Medical Physics Volume Magnetic Resonance Imaging Mri Physics

Is RHT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.088
52 Week Low 0.038
Average Volume 274,946
200-Day Moving Average 0.060
50-Day Moving Average 0.056
20-Day Moving Average 0.049
10-Day Moving Average 0.043
Average True Range 0.002
RSI (14) 39.02
ADX 34.19
+DI 14.567
-DI 59.449
Chandelier Exit (Long, 3 ATRs) 0.055
Chandelier Exit (Short, 3 ATRs) 0.044
Upper Bollinger Bands 0.063
Lower Bollinger Band 0.036
Percent B (%b) 0.09
BandWidth 55.397
MACD Line -0.005
MACD Signal Line -0.004
MACD Histogram -0.0011
Fundamentals Value
Market Cap 16.91 Million
Num Shares 445 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 12.67
Price-to-Sales 18.86
Price-to-Book 7.18
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.038
Resistance 3 (R3) 0.038 0.038 0.038
Resistance 2 (R2) 0.038 0.038 0.038 0.038
Resistance 1 (R1) 0.038 0.038 0.038 0.038 0.038
Pivot Point 0.038 0.038 0.038 0.038 0.038
Support 1 (S1) 0.038 0.038 0.038 0.038 0.038
Support 2 (S2) 0.038 0.038 0.038 0.038
Support 3 (S3) 0.038 0.038 0.038
Support 4 (S4) 0.038